In April 2018, S&P raised its outlook on CHI’s rated debt to positive on its potential to merge with San Francisco-based Dignity Health.
“The outlook revision to positive reflects CHI’s potential combination with Dignity Health as outlined in its definitive merger agreement combined with incrementally improved, though still weak, performance of CHI’s continuing operations,” said S&P credit analyst Martin Arrick.
S&P also assigned the proposed bonds a positive outlook.
More articles on healthcare finance:
TransUnion Healthcare keeping contract with VA
Central Learning launches 3rd coding contest
S&P ratings on ProMedica debt unchanged after HCR ManorCare acquisition
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
